促销时间表 MicroPort CardioFlow Medtech Corporation
先进的时间表
简单图表
关于公司
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
每日价格变化: |
0% (0.1293) |
每周价格变化: |
0% (0.1293) |
每月价格变化: |
-60.82% (0.33) |
3个月内价格变化: |
-60.82% (0.33) |
六个月内的价格变化: |
-60.82% (0.33) |
每年价格变化: |
-60.82% (0.33) |
年初以来价格变化: |
-60.82% (0.33) |
|
低估
姓名 |
意义 |
年级 |
P/S |
16.9 |
1 |
P/BV |
0.3427 |
10 |
P/E |
0 |
0 |
EV/EBITDA |
0 |
0 |
全部的: |
|
3.88 |
|
效率
姓名 |
意义 |
年级 |
ROA, % |
-2.57 |
0 |
ROE, % |
-2.85 |
0 |
全部的: |
|
0 |
|
|
股息
姓名 |
意义 |
年级 |
Div yield, % |
0 |
0 |
DSI |
0 |
0 |
全部的: |
|
0 |
|
责任
姓名 |
意义 |
年级 |
Debt/EBITDA |
0 |
10 |
全部的: |
|
10 |
|
成长冲动
姓名 |
意义 |
年级 |
盈利能力 Revenue, % |
-50.42 |
0 |
盈利能力 Ebitda, % |
0 |
0 |
盈利能力 EPS, % |
-82.22 |
0 |
全部的: |
|
0 |
|
导师 |
职称 |
支付 |
出生年份 |
Mr. Jeffrey R Lindstrom |
President, GM & Executive Director |
N/A |
1967 (57 年) |
Ms. Luying Yan |
VP & Executive Director |
N/A |
1982 (42 年) |
Mr. Liang Zhao |
Executive Director & First VP of Total Solutions |
N/A |
1980 (44 年) |
Ms. Xiangmei Li |
Joint Company Secretary |
N/A |
|
Ms. Lok Yee Chan A.C.I.S., A.C.S. |
Joint Company Secretary |
N/A |
1990 (34 年) |